EP 1163516 A1 20011219 - EFFECT OF BREFELDIN A ON ANTIGEN-PRESENTING CELLS
Title (en)
EFFECT OF BREFELDIN A ON ANTIGEN-PRESENTING CELLS
Title (de)
WIRKUNG VON BREFELDIN A AUF ANTIGEN-PRÄSENTIERENDE ZELLEN
Title (fr)
EFFET DE LA BREFELDINE A SUR LES CELLULES PRESENTATRICES D'ANTIGENES
Publication
Application
Priority
- FR 0000636 W 20000316
- FR 9903304 A 19990317
Abstract (en)
[origin: FR2791142A1] The invention concerns a method for screening immunogenic peptides using Brefeldin A to enhance the effect of presentation of said peptides by antigen-presenting cells. The invention also concerns immunogenic peptides obtainable by said method, in particular peptide P100, and the use of a peptide P100 compound for preparing a medicine designed to treat and/or prevent EBV-induced diseases, in particular for treating and/or preventing Burkitt lymphoma, nasopharyngeal carcinoma, and/or Hodgkin's disease.
IPC 1-7
G01N 33/50; C07K 14/05; A61K 38/00; A61K 39/245; A61K 9/00; A61K 31/365
IPC 8 full level
A61K 39/245 (2006.01); C07K 14/05 (2006.01); G01N 33/50 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP)
A61K 39/12 (2013.01); A61K 39/245 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C07K 14/005 (2013.01); G01N 33/5047 (2013.01); A61K 39/00 (2013.01); C12N 2710/16222 (2013.01); C12N 2710/16234 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
FR 2791142 A1 20000922; FR 2791142 B1 20010622; AU 3298800 A 20001004; EP 1163516 A1 20011219; WO 0055622 A1 20000921
DOCDB simple family (application)
FR 9903304 A 19990317; AU 3298800 A 20000316; EP 00910959 A 20000316; FR 0000636 W 20000316